BML Capital Management, LLC - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 1 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BML Capital Management, LLC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,012,7281,087,9611.74%
Other shareholders

There were no reported owners of JOUNCE THERAPEUTICS INC in Q2 2023.

NameSharesValueWeighting ↓
View complete list of JOUNCE THERAPEUTICS INC shareholders